Literature DB >> 22559758

Can we reliably benchmark health technology assessment organizations?

Michael Drummond1, Peter Neumann, Bengt Jönsson, Bryan Luce, J Sanford Schwartz, Uwe Siebert, Sean D Sullivan.   

Abstract

OBJECTIVES: In recent years, there has been growth in the use of health technology assessment (HTA) for making decisions about the reimbursement, coverage, or guidance on the use of health technologies. Given this greater emphasis on the use of HTA, it is important to develop standards of good practice and to benchmark the various HTA organizations against these standards.
METHODS: This study discusses the conceptual and methodological challenges associated with benchmarking HTA organizations and proposes a series of audit questions based on a previously published set of principles of good practice. RESULTS AND
CONCLUSIONS: It is concluded that a benchmarking exercise would be feasible and useful, although the question of who should do the benchmarking requires further discussion. Key issues for further research are the alternative methods for weighting the various principles and for generating an overall score, or summary statement of adherence to the principles. Any weighting system, if developed, would need to be explored in different jurisdictions to assess the extent to which the relative importance of the principles is perceived to vary. Finally, the development and precise wording of the audit questions requires further study, with a view to making the questions as unambiguous as possible, and the reproducibility of the assessments as high as possible.

Mesh:

Year:  2012        PMID: 22559758     DOI: 10.1017/S0266462312000098

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

Review 1.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

2.  Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review.

Authors:  Angela Rocchi; Isabelle Chabot; Judith Glennie
Journal:  Clinicoecon Outcomes Res       Date:  2015-06-03

3.  Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.

Authors:  Tim Mathes; Esther Jacobs; Jana-Carina Morfeld; Dawid Pieper
Journal:  BMC Health Serv Res       Date:  2013-09-30       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.